Benign asbestos pleural diseases

Current Opinion in Pulmonary Medicine

Volumn 9, Issue 4, 2003, Pages 266-271

  Chapman, Stephen J ^a   Cookson, William O C ^b   Musk, A William ^c   Lee, Y C Gary ^a,b,d  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d Asthma and Allergy Research Institute   (Australia)

Author keywords

Asbestos; Diffuse pleural thickening; Pleural mesothelial cell; Pleural plaques

Indexed keywords

ASBESTOS;

ATELECTASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; LUNG FUNCTION TEST; PARIETAL LOBE; PATHOGENESIS; PLEURA DISEASE; PLEURA PLAQUE; PLEURA THICKENING; PREDICTION; RADIOLOGY; REVIEW;

ASBESTOS; ASBESTOSIS; HUMANS; MINERAL FIBERS; PLEURAL DISEASES;

EID: 0038677035     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200307000-00004     Document Type: Review

References (70)

1. Ferrer J, Valero JG, Castillo JM: Pleural reaction to mineral dust. In Textbook of Pleural Diseases. Edited by Light RW, Lee YCG. London: Arnold Press; 2003:109-119. This chapter provides a detailed summary of the effects of asbestos and talc on mesothelial cells.
2. Landrigan PJ, Nicholson WJ, Suzuki Y, et al.: The hazards of chrysotile asbestos: a critical review. Ind Health 1999, 37:271-280.
3. Emri S, Demir A, Dogan M, et al.: Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicol Lett 2002, 127:251-257.
4. Topcu F, Bayram H, Simsek M, et al.: High-resolution computed tomography in cases with environmental exposure to asbestos in Turkey. Respiration 2000, 67:139-145.
5. Dumortier P, Rey F, Viallat JR, et al.: Chrysotile and tremolite asbestos fibres in the lungs and parietal pleura of Corsican goats. Occup Environ Med 2002, 59:643-646.
6. Musk AW, De Klerk NH: Benign asbestos pleural diseases. In Textbook of Pleural Diseases. Edited by Light RW, Lee YCG. London: Arnold Press; 2003:428-434. This chapter provides an excellent overview of the clinical features and the management of various types of benign asbestos pleural diseases.
7. Rudd RM: New developments in asbestos-related pleural diseases. Thorax 1996, 51:210-216.
8. Van Cleemput J, De Raeve H, Verschakelen JA, et al.: Surface of localized pleural plaques quantitated by computed tomography scanning: no relation with cumulative asbestos exposure and no effect on lung function. Am J Respir Crit Care Med 2001, 163:705-710.
9. Kilburn KH, Warshaw RH: Abnormal lung function associated with asbestos disease of the pleura, the lung and both: a comparative analysis. Thorax 1991, 46:33-38.
10. Wang XR, Yano E, Wang M, et al.: Pulmonary function in long-term asbestos workers in China. J Occup Environ Med 2001, 43:623-629.
11. Copley SJ, Wells AU, Rubens MB, et al.: Functional consequences of pleural disease evaluated with chest radiography and CT. Radiology 2001, 220:237-243. A simple scoring method was shown to quantify pleural changes on CT that correlated with changes in pulmonary functions.
12. Jones RN, McLoud T, Rockoff SD: The radiographic pleural abnormalities in asbestos exposure: relationship to physiologic abnormalities. J Thorac Imaging 1988, 3:57-66.
13. Lee YCG, Singh B, Pang SC, et al.: Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis. Occup Environ Med 2003, 60:201-206.
14. Mukherjee S, De Klerk NH, Palmer LJ, et al.: Chest pain in asbestos-exposed individuals with benign pleural and parenchymal disease. Am J Respir Crit Care Med 2000, 162:1807-1811.
15. Sjogren B: Association between pleural plaques and coronary heart disease. Scand J Work Environ Health 2001, 27:420-421.
16. Korhola O, Hiltunen A, Karjalainen A, et al.: Association between pleural plaques and coronary heart disease. Scand J Work Environ Health 2001, 27:154-155.
17. Hillerdal G, Ozesmi M: Benign asbestos pleural effusion: 73 exudates in 60 patients. Eur J Respir Dis 1987, 71:113-121.
18. Cookson WOC, De Klerk NH, Musk AW, et al.: Benign and malignant pleural effusions in former Wittenoom crocidolite millers and miners. Aust N Z J Med 1985, 15:731-737.
19. Lee YCG, Dean A, Thompson RI, et al.: Clinical and palliative care aspects of malignant mesothelioma. In Mesothelioma. Edited by Robinson BWS, Chahinian P. London: Martin Dunitz; 2002:111-126.
20. Robinson BWS, Musk AW: Benign asbestos pleural effusion: diagnosis and course. Thorax 1981, 36:896-900.
21. McLoud TC, Woods BO, Carrington CB, et al.: Diffuse pleural thickening in an asbestos-exposed population: prevalence and causes. AJR Am J Roentgenol 1985, 144:9-18.
22. Lynch DA, Gamsu G, Aberle DR: Conventional and high-resolution tomography in the diagnosis of asbestos-related diseases. Radiographics 1989, 9:523-551.
23. McGavin C, Smith K, Sykes L. Diffuse asbestos-related pleural fibrosis: a poor guide to heavy dust exposure. Thorax 2002, 57(suppl III):iii-35.
24. Yates DH, Browne K, Stidolph PN, et al.: Asbestos-related bilateral diffuse pleural thickening: natural history of radiographic and lung function abnormalities. Am J Respir Crit Care Med 1996, 153:301-306.
25. Singh B, Eastwood PR, Finucane KE, et al.: Effect of asbestos-related pleural fibrosis on excursion of the lower chest wall and diaphragm. Am J Respir Crit Care Med 1999, 160:1507-1515.
26. Munoz X, Roger A, Pallisa E, et al.: Ventilatory insufficiency due to asbestos-related diffuse pleural fibrosis successfully treated with noninvasive home mechanical ventilation. Respiration 2001, 68:533-536.
27. Hillerdal G: Rounded atelectasis. Clinical experience with 74 patients. Chest 1989, 95:836-841.
28. Batra P, Brown K, Hayashi K, et al.: Rounded atelectasis. J Thorac Imaging 1996, 11:187-197.
29. Chen C, Newman L: Rounded atelectasis complicated by obstructive pneumonia and pulmonary artery thrombosis. Chest 1990, 98:1283-1285.
30. Dernevik L, Gatzinsky P: Long term results of operation for shrinking pleuritis with atelectasis. Thorax 1985, 40:448-452.
31. Whitman GJ, Niklason LT, Pandit M, et al.: Dual-energy digital subtraction chest radiography: technical considerations. Curr Probl Diagn Radiol 2002, 31:48-62.
32. Lee YCG, Runnion CK, Pang SC, et al.: Increased body mass index is related to apparent circumscribed pleural thickening on plain chest radiographs. Am J Ind Med 2001, 39:112-116.
33. Friedman AC, Fiel SB, Fisher MS, et al.: Asbestos-related pleural disease and asbestosis: a comparison of CT and chest radiography. AJR Am J Roentgenol 1988, 150:269-275.
34. Al Jarad N, Poulakis N, Pearson MC, et al.: Assessment of asbestos-induced pleural disease by computed tomography - correlation with chest radiograph and lung function. Respir Med 1991, 85:203-208.
35. Peacock C, Copley SJ, Hansell DM: Asbestos-related benign pleural disease. Clin Radiol 2000, 55:422-432.
36. Roach HD, Davies GJ, Attanoos R, et al.: Asbestos: when the dust settles an imaging review of asbestos-related disease. Radiographics 2002, 22: S167-S184.
37. De Raeve H, Verschakelen JA, Gevenois PA, et al: Observer variation in computed tomography of pleural lesions in subjects exposed to indoor asbestos. Eur Respir J 2001, 17:916-921.
38. Aberle DR: High-resolution computed tomography of asbestos-related diseases. Semin Roentgenol 1991, 26:118-131.
39. Gevenois PA, De Vuyst P, Dedeire S, et al.: Conventional and high-resolution CT in asymptomatic asbestos-exposed workers. Acta Radiol 1994, 35:226-229.
40. Copley SJ, Lee YCG, Sivakumaran P, et al.: Use of high resolution computed tomography (HRCT) to determine relative contribution of asbestos-induced pleuro-pulmonary disease and emphysema to lung function impairment [abstract]. Am J Respir Crit Care Med 2003, 167:A987.
41. Boraschi P, Neri S, Braccini G, et al.: Magnetic resonance appearance of asbestos-related benign and malignant pleural diseases. Scand J Work Environ Health 1999, 25:18-23.
42. Kiryu T, Ohashi N, Matsui E. et al.: Rounded atelectasis: delineation of enfolded visceral pleura by MRI. J Comput Assist Tomogr 2002, 26:37-38.
43. Nishimura SL, Braoddus VC: Asbestos-induced pleural disease. Clin Chest Med 1998, 19:311-329.
44. Viallat JR, Raybuad F, Passarel M, et al.: Pleural migration of chrysotile fibers after intratracheal injection in rats. Arch Environ Health 1986, 41:282-286.
45. Dodson RF, Williams MGJ, Corn CJ, et al.: Asbestos content of lung tissue, lymph nodes, and pleural plaques from former shipyard workers. Am Rev Respir Dis 1990, 142:843-847.
46. Boutin C, Dumortier P, Rey F, et al.: Black spots concentrate oncogenic asbestos fibers in the parietal pleura. Thoracoscopic and mineralogic study. Am J Respir Crit Care Med 1996, 153:444-449.
47. Mitchev K, Dumortier P, De Vuyst P: "Black spots" and hyaline pleural plaques on the parietal pleura of 150 urban necropsy cases. Am J Surg Pathol 2002, 26:1198-1206.
48. Manning CB, Vallyathan V, Mossman BT: Diseases caused by asbestos: mechanisms of injury and disease development. Int Immunopharmacol 2002, 2:191-200.
49. Stanton MF, Layard M, Tegeris A, et al.: Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst 1981, 67:965-975.
50. Kamp DW, Weitzman SA: The molecular basis of asbestos induced lung injury. Thorax 1999, 54:638-652.
51. Boylan AM, Sanan DA, Sheppard D, et al.: Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin alpha v beta 5. J Clin Invest 1995, 96:1987-2001.
52. Sahn SA, Antony VB: Pathogenesis of pleural plaques. Relationships of early cellular response and pathology. Am Rev Respir Dis 1984, 130:884-887.
53. Lee YCG: Mesothelial cell in pleural disease: an active player or innocent bystander. Presented at the 7th Congress of the Asian Pacific Society of Respirology. Edited by Luh K-T. Taipei, Taiwan, 2002:101-105.
54. Boylan AM, Ruegg C, Kim KJ, et al.: Evidence of a role for mesothelial cell-derived interleukin-8 in the pathogenesis of asbestos-induced pleurisy in rabbits. J Clin Invest 1992, 89:1257-1267.
55. Choe N, Tanaka S, Xia W, et al.: Pleural macrophage recruitment and activation in asbestos-induced pleural injury. Environ Health Perspect 1997, 105(suppl 5):1257-1260.
56. Tanaka S, Choe N, Iwagaki A, et al.: Asbestos exposure induces MCP-1 secretion by pleural mesothelial cells. Exp Lung Res 2000, 26:241-255.
57. Choe N, Zhang J, Iwagaki A, et al.: Asbestos exposure upregulates the adhesion of pleural leukocytes to pleural mesothelial cells via VCAM-1. Am J Physiol 1999, 277:L292-L300.
58. Kaarteenaho-Wiik R, Lakari E, Soini Y, et al.: Tenascin expression and distribution in pleural inflammatory and fibrotic diseases. J Histochem Cytochem 2000, 48:1257-1268.
59. Light RW, Cheng DS, Lee YCG, et al.: A single intrapleural injection of transforming growth factor beta-2 produces an excellent pleurodesis in rabbits. Am J Respir Crit Care Med 2000, 162:98-104.
60. Lee YCG, Lane KB, Parker RE, et al.: Transforming growth factor beta-2 (TGFβ2) produces effective pleurodesis in sheep with no systemic complications. Thorax 2000, 55:1058-1062.
61. Jagirdar J, Lee TO, Reibman J, et al.: Immunohistochemical localization of transforming growth factor beta isoforms in asbestos-related diseases. Environ Health Perspect 1997, 105(suppl 5):1197-1203.
62. Adamson JYR, Bakowska J, Bowden DH: Mesothelial cell proliferation after instillation of long or short asbestos fibers into mouse lung. Am J Pathol 1993, 142:1209-1216.
63. Sekhon H, Wright J, Churg A: Effects of cigarette smoke and asbestos on airway, vascular and mesothelial cell proliferation. Int J Exp Pathol 1995, 76:411-418.
64. Adamson IY, Bakowska J, Prieditis H: Proliferation of rat pleural mesothelial cells in response to hepatocyte and keratinocyte growth factors. Am J Respir Cell Mol Biol 2000, 23:345-349.
65. Adamson IYR, Bakowska J: Relationship of keratinocyte growth factor and hepatocyte growth factor levels in rat lung lavage fluid to epithelial cell regeneration after bleomycin. Am J Pathol 1999, 155:949-954.
66. Lee YCG, Lane KB: Cytokines in pleural diseases. In Textbook of Pleural Diseases. Edited by Light RW, Lee YCG. London: Arnold Press; 2003:63-89. A comprehensive review of the effects of cytokines in various pleural diseases, including asbestos-related pleural disorders.
67. Mayall FG, Jacobson G, Wilkins R: Mutations of p53 gene and SV40 sequences in asbestos associated and non-asbestos-associated mesotheliomas. J Clin Pathol 1999, 52:291-293.
68. Carbone M, Fisher S, Powers A, et al.: New molecular and epidemiological issues in mesothelioma: role of SV40. J Cell Physiol 1999, 180:167-172.
69. Cicala C, Pompetti F, Carbone M: SV40 induces mesotheliomas in hamsters. Am J Pathol 1993, 142:1524-1533.
70. Lee YCG, De Klerk NH, Henderson DW, et al.: Malignant mesothelioma. In Occupational Disorder of the Lung, Recognition, Management and Prevention. Edited by Hendrick DJ, Burge PS, Beckett WS, et al. London: WB Saunders; 2002:359-379.